The AMCP Nexus meeting addressed healthcare policy issues, including PBM reform, Medicaid reform, and the Inflation Reduction ...

The Primary Healthcare Commission announces the Community Drug Formulary mechanism and promulgates the Guidelines of Practice ...

Tunstall: Medicaid cuts in HR 1 are likely to have an immediate impact. According to government estimates, these cuts could result in 17 million Americans losing their health coverage. Medicaid is a ...

The Massachusetts Health Policy Commission (HPC) announced it will hold its Annual Health Care Cost Trends Hearing on November 12, 2025. This ...

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...

Discover how generative AI is reshaping clinical care with real-world examples, challenges, and expert advice for AI adoption ...

Reimagining pharmacy benefits modular empowers health systems with technology-driven control, transparency, and improved patient care management.

Research and development (R&D) expenses were $40.2 million for the third quarter of 2025, compared to $45.4 million for the comparable period in 2024. The decrease was primarily related to the ...

Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...

With Medicare prescription-drug benefits likely to make major formulary changes in 2026, beneficiaries who hope to minimize ...

Access to pharmacy and medical claims data is among the most fundamental needs for evaluating a health plan's costs and the services its members may need. Unfortunately, many entrenched traditional ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...